Index
Checking point of information
at the time of initial public offering.
AI Analysis
■AI Analysis
AI statistically analyzes IPO information to identify trends.
The closer the number is to 5, the higher the rate of increase in the initial price relative to the offering price.
| popularity | scale-criteria | offering-criteria | exchange-criteria | market-condition | Business-criteria |
| 1 | 2 | 5 | 5 | 4 | 1 |
*This is an analysis of trends and does not guarantee any results.
This is not a solicitation to buy or sell stocks, nor is it investment advice.
*Please check the disclaimer for details.
■AI Analysis Chart
A group of stocks listed in the past
with similar IPO condition trends
| Name | Rate of change
(Inicial Price) |
|
| +10.0% |
|
| +22.5% |
|
| -19.6% |
|
| -0.2% |
|
| -14.5% |
|
| +4.0% |
CompanyOverview
- Company Name：STELLA PHARMA CORPORATION
- Business：BNCT（ホウ素中性子捕捉療法）に使用されるホウ素医薬品の開発及び製造販売.
- The industry sector is Pharmaceutical.
- Scheduled to be listed on MOTHERS.
- The company size is that assumed market capitalization is
approx. 93 Million JPY (excluded public offering), approx. 127 Million JPY (included public offering).
- The lead manager is みずほ.
https://stella-pharma.co.jp/
Initial Public Offering Memo
■ Market Cap | Offering rate | Dilution rate | lock-up information
- The company size is assumed market capitalization is
approx. 93 Million JPY (excluded new issues), approx. 127 Million JPY (included new issues).
- The total amount of new issues is 34.0 Million JPY.
- The total amount of public offering is 5.1 Million JPY.
- The dilution ratio from the new issues is 37%.
- Rate of offering is aprrox. 6%.
- The number of outstanding shares is 20,137,400 shares (excluded new issues),
27,528,800 shares (included new issues).
- The number of diluted shares for stock acquisition rights is 978,800 shares.
- Date of 90-day lockup release (initially scheduled) is July 20, 2021.
- Date of 180-day lockup release (initially scheduled) is October 18, 2021.
■ Book building schedule | Payment schedule
- Book building Period *1：April 6, 2021(Tue.) - April 12, 2021(Mon.)
- Priced date *2 ：April 13, 2021(Tue.)
- Payment Period *3 ：April 14, 2021(wed.) - April 19, 2021(Mon.)
- Listing Date ：April 22, 2021(Thu.)
*1:(Period for applying lottery to obtain the right to purchase)
*2:(The date when the purchase price is determined)
*3:(Period for expressing your intent to purchase and payment,if you are selected in the lottery)
■ Detail of new issue or public offering
- Unit of application：100 shares (Minimum deposit amount is 46,000 JPY.)
- Assumed issue price：510 JPY
- Tentatively price range：400 JPY - 460 JPY
- Public offering price：460 JPY
- The initial price on listed：712 JPY(＋54.8％)
- Newly Issued Shares：7,391,400 shares (Domestic：5,494,400 shares ＋ Overseas：1,897,000 shares)
- Public offering shares：1,108,600 shares (Domestic：1,108,600 shares ＋ Overseas：0 shares)
- Number of domestic unit：66,030 Unit
- The lead manager is みずほ証券.
- The another securities companies are 大和証券/ＳＭＢＣ日興証券/いちよし証券/エース証券/岩井コスモ証券/ＳＢＩ証券/楽天証券.
| みずほ |
大和 |
ＳＭＢＣ日興 |
いちよし |
エース |
岩井コスモ |
ＳＢＩ |
楽天 |
| Lead |
Sub |
Sub |
Sub |
Sub |
Sub |
Sub |
Sub |
■ New issue or public offering - condition history
|
Update
date |
Assumed issue
price
(JPY) |
Tentatively
price range
(JPY) |
Public offering
price
(JPY) |
| Initial | 2021-03-19 | 510 JPY | | |
| Application period | 2021-04-05 | | 400 - 460 JPY | |
| Priced | 2021-04-13 | | | 460 JPY |
|
Update
date |
New issues
total shares |
New issues
(Overseas) |
PO&OA
total shares |
PO
(Domestic) |
PO
(Overseas) |
OA
(Domestic) |
OA
(Overseas) |
| Initial | 2021-03-19 | 7,391,400 | 0 | 1,108,600 | 0 | 0 | 1,108,600 | 0 |
| Application period | 2021-04-05 | 7,391,400 | 0 | 1,108,600 | 0 | 0 | 1,108,600 | 0 |
| Priced | 2021-04-13 | 7,391,400 | 1,897,000 | 1,108,600 | 0 | 0 | 1,108,600 | 0 |
※：( ) indicates the breakdown.
e.g. In the case of a PO(overseas), there are domestic and overseas allotments of the public offering, of which the overseas allotment is indicated.
PO : Public offering OA : Over allotment
